Abstract
It is possible that SGLT2 inhibitors trigger euglycemic diabetic ketoacidosis in some patients. Possible mechanism of euglycemic DKA induced by SGLT2 inhibitors is illustrated.
MeSH terms
-
Blood Glucose
-
Diabetic Ketoacidosis / chemically induced*
-
Humans
-
Hypoglycemic Agents / adverse effects*
-
Hypoglycemic Agents / pharmacology
-
Metabolic Networks and Pathways / drug effects
-
Sodium-Glucose Transporter 2
-
Sodium-Glucose Transporter 2 Inhibitors*
Substances
-
Blood Glucose
-
Hypoglycemic Agents
-
SLC5A2 protein, human
-
Sodium-Glucose Transporter 2
-
Sodium-Glucose Transporter 2 Inhibitors